Previous reports from our laboratory described the detection of a suppressor factor which inhibited the phagocytic activity of a macrophage subset in murine cryptococcosis and in classical models of immune tolerance. The suppressor factor was originally named PIL (phagocytosis-inhibiting lymphokine) but has recently been renamed TsFmp (T suppressor factor for macrophage phagocytosis) because it was found to resemble the antigen-specific I-J-restricted suppressor factors described by others. The current investigation revealed that TsFmp acted rapidly upon the macrophage (15 min or less) to exert its effect of inhibiting the phagocytic process. The time for the macrophage to recover from the effects of TsFmp was likewise very rapid.
Previous reports from our laboratory described the detection of a suppressor factor which inhibited the phagocytic activity of a macrophage subset in murine cryptococcosis and in classical models of immune tolerance. The suppressor factor was originally named PIL (phagocytosis-inhibiting lymphokine) but has recently been renamed TsFmp (T suppressor factor for macrophage phagocytosis) because it was found to resemble the antigen-specific I-J-restricted suppressor factors described by others. The current investigation revealed that TsFmp acted rapidly upon the macrophage (15 min or less) to exert its effect of inhibiting the phagocytic process. The time for the macrophage to recover from the effects of TsFmp was likewise very rapid. The ability of TsFmp to inhibit phagocytosis was limited to engulfment of particles by Fc and mannan receptors and did not extend to phagocytosis via complement receptors or by nonspecific mechanisms. The macrophage subset that responded to TsFmp was determined to be in the I-A' and I-J-IM+ subset.
We previously described (2) (3) (4) 11 ) the detection of a T suppressor factor that inhibited the phagocytic activity of a macrophage subset in mice infected with Cryptococcus neoformans or in mice injected with soluble cryptococcal antigens. The suppressor cell responsible for the production of the suppressor factor was identified as an Lyt-2+, I-J+ T lymphocyte that secreted the factor into tissue culture medium only after stimulation with specific antigen. The suppressor factor had a molecular size of approximately 70,000 daltons and was genetically restricted in its activity. That restriction was mapped to I-J as defined by the difference between B10.A(3R) and B1O.A(5R) mice. The factor was absorbed by cryptococcal antigen, and its activity could be blocked by anti-I-J alloantiserum.
The macrophage that responded to the factor was present among a very small subset (10 to 20%) of peritoneal exudate cells, but very little other information regarding the affected macrophage was known. Originally we named the factor PIL (phagocytosis-inhibiting lymphokine). However, because recent information regarding the size and molecular structure of the factor placed it in the class of antigen-specific suppressor factors that have been described in haptenic systems, we renamed the factor TsFmp.
The present investigation was aimed at further analysis of the response of the macrophage to the suppressor factor. Included was a kinetic analysis of the ability of TsFmp to inhibit the phagocytic process as well as determination of the time required for the macrophage to recover from the effects of TsFmp. The effect on phagocytosis via different membrane receptors was examined. Additionally, the susceptible macrophage was evaluated for its expression of the membrane markers I-A and I-J-IM.
MATERIALS AND METHODS
Abbreviations used. The (3) . Normal control supernatants were prepared in a similar fashion, except that spleen cells were harvested from normal mice. The normal controls showed that prior sensitization of mice with SCPA was required for suppressor factor production and that the polysaccharide antigen itself did not produce the effect. Later, a T-T hybridoma was produced (2) 3 days previously with 0.25 ml of 10% aged thioglycollate medium. The cells were washed and suspended to 2 x 105 cells per ml of RPMI 1640 containing 10% fetal calf serum, and 0.5 ml of the cell suspension was dispensed into the wells of a eight-chambered Lab-Tek slide (Miles Laboratories, Inc., Elkhart, Ind.). The monolayers were allowed to adhere to the surface of the slides for various times as indicated. At the time of assay the medium was removed from the wells of the slides and replaced with 0.25 ml of test or control supernatant. During kinetic analysis the supernatants were incubated on the monolayers for various periods of time ranging from 15 min to 24 h. However, after the completion of these experiments the routine procedure involved treatment of the macrophage monolayers with supernatant for 1 h. After incubation of the monolayer at 37°C in 5% C02, the supernatants were removed and replaced with 0.5 ml of a suspension of nonencapsulated cryptococci (M7) at a concentration of 5 x 106 cells per ml, and the slides were incubated for an additional 2 h. Subsequently, the slides were washed by removing the plastic top and gently dipping the slides in beakers of warm PBS to remove extracellular cryptococci. The slides were then air dried and stained with Camco Quick Stain (Scientific Products Inc., Detroit, Mich.). In some instances phagocytosis via Fc-receptormediated, complement receptor, and nonspecific mechanisms was evaluated. In these experiments EA or EAC complexes and latex particles at 107 particles per ml were used instead of cryptococci. Assays utilizing EAC complexes were incubated for 2 h; however, ingestion of EA and latex was much quicker and required only 1 h of incubation. After phagocytosis of erythrocytes the slides were treated with 0.85% ammonium chloride solution before washing to lyse extracellular erythrocytes but otherwise were washed and stained as described for the M7 procedure. In all phagocytic assays four replicate determinations were performed for each experimental condition. At least 100 cells were evaluated, and the percentage of macrophages containing one or more particles was determined.
Separation of macrophage subpopulations by panning. Peritoneal exudate cells were separated based upon their expres-
on August 14, 2017 by guest http://iai.asm.org/ Downloaded from sion of I-A and or I-J-IM by a panning procedure. The plates used for panning were treated with 10 ,ug of affinity-purified F(ab')2 goat anti-mouse immunoglobulin per ml suspended in PBS for 18 h at 4°C. After the antibody solution was removed and plates were washed with PBS three times, the plates were used for cell separations. Cells (107 cells per ml) to be separated were treated with 50% fetal calf serum for 30 min on ice to block Fc receptors. They were then washed and treated at 4°C with anti-I-J or anti-I-A antiserum at dilutions previously shown to be appropriate (1:10). After 20 min of incubation the cells were washed and then diluted in PBS to a concentration of 1 x 107 per ml. The cell suspension (1.5 ml) was then placed in the tissue culture well (12-well plate) and incubated on ice for 1 h. After this incubation the nonadherent fraction was tested for its susceptibility to TsFmp as described above. The adherent fraction could not be evaluated because after this fraction was scraped from the bottom of the tissue culture well, it would not adhere to the Lab-Tek slides used in the phagocytic assay. The effectiveness of the I-A panning procedure was followed by indirect immunofluorescence analysis of the separated populations and was shown to remove the I-A' population. Before panning macrophage populations contained 16 to 33% I-A' cells. After panning with specific anti-I-A the nonadherent fractions were 5 to 6% I-A'. I-A+ cells in the adherent fraction were slightly enriched (17 to 40%) compared with unfractionated cells. This was attributed to the fact that even though the cells were panned at 4°C a substantial number of I-A-macrophages were able to adhere to the plastic surface. When macrophages were panned by using nonspecific anti-I-A antibodies, equal numbers of I-A+ cells were found in the adherent and nonadherent fractions: these percentages were similar to those in the unfractionated population. These results indicated that the ability to adhere to plastic at 4°C was a random event in both the I-A' and I-A-populations. Because it is difficult to detect I-J-IM by conventional serologic procedures, we relied upon the fact that the dilution of anti-I-J used would remove suppressor cell activity from spleen cell populations (3) Expression of I-A and I-J-IM on the membrane of the affected macrophage. The macrophage subset that was affected by TsFmp was small, accounting for only 10 to 20% of the total macrophage population. The size of the subset and the I-J genetic restrictions previously reported for the effect of the factor upon the macrophage suggested that the macrophage may express I-A and/or I-J-IM on its membrane. Experiments to determine these possibilities were conducted by removing I-A-and I-J-IM-positive subsets by panning. The results of these experiments are shown in Tables 4 and  5 . Treatment of C3HeB/FeJ macrophages with anti-I-Ak followed by panning on an anti-mouse immunoglobulin plate effectively removed the affected macrophage from the suspension of peritoneal exudate cells. However, treatment with anti-I-A" did not remove the population. Likewise, when C57BL/6 macrophages were treated with anti-I-Ab the affected macrophage was removed, but it remained in the population when the macrophages were treated with anti_Ak.
Alloantisera prepared by cross-immunization of mouse strains differing only at the I-J locus contain antibodies reactive against I-J antigens as well as molecules on the macrophage membrane that interact with I-J and which have been called I-J-IM (7) . For this reason I-J alloantisera were used to remove I-J-IM-positive macrophages from the peritoneal cell populations by panning (Table 5 ). Treatment of C3HeB/FeJ macrophages with anti-IlJk followed by panning removed the susceptible subset from the population. Treat- ment with anti-IlJb was ineffective. The reciprocal experiment with C57BL/6 macrophages treated with anti_IlJk or anti-I-Jb showed that only the anti-I-Jb treatment could remove the macrophage that was responsive to TsFmp.
DISCUSSION
We previously examined a suppressor cell mechanism that occurred in mice infected with C. neoformans and in mice injected with soluble cryptococcal antigens (2-4, 11 ). The suppressor cell was identified as belonging to the Lyt-2+, I-J+ subset. This suppressor cell required interaction with specific cryptococcal antigen in vitro before it secreted a soluble suppressor factor into tissue culture medium. The factor was originally named PIL; however, recent investigations (2) showed that the factor had a molecular size (70,000 daltons) and other characteristics (idiotypic and I-J restricted) that placed it in a category of factors that limit cutaneous hypersensitivity responses to haptens (1, 5) and the delayed-type hypersensitivity response in cryptococcosis (9, (12) (13) (14) . For this reason we changed the name of the factor to be consistent with the nomenclature established for this group of antigen specific suppressor factors to TsFmp.
Although much was known about the identity of the lymphocyte that produced the suppressor factor and the factor itself, very little was known about the macrophage that responded to the factor. A kinetic study of the time required for TsFmp-macrophage interaction before inhibition of phagocytosis was inhibited showed that the interac- Table 4. tion was very rapid (15 min or less). Thus, it was apparent that phagocytosis was inhibited as soon as the suppressor molecule interacted with the macrophage membrane and that no period of macrophage differentiation was required.
This would rule out any hypothesis that TsFmp causes a change in the macrophage, such as activation, which would concomitantly reduce phagocytosis. Additionally, the macrophage was able to recover from the effects of TsFmp rapidly; only 15 min incubation in tissue culture medium after TsFmp treatment resulted in complete recovery from the effects of the factor. The actual time of recovery may have been longer than 15 min, since the phagocytic assay itself required 2 h of incubation. However, we can state that recovery occurred within 2 h and probably occurred more rapidly. If the interaction of TsFmp and the macrophage resulted in modulation of phagocytic receptors from the surface of the cell, one might expect that a period of time would be required for the cell to synthesize more receptors. This would be in keeping with what is known about the removal of immunoglobulin molecules from the surface of B cells during the modulation process (18) . The rapidity of the recovery of the macrophage from the effects of TsFmp suggests that the phagocytic receptors are not modulated but that the receptors may be temporarily blocked by the suppressor factor. Proof of this hypothesis will require examination of the fate of the phagocytic receptor after interaction with TsFmp and the ability of the suppressor factor to inhibit binding of particles and/or receptor ligands. These experiments are planned for the near future. Rapid recovery from the effects of TsFmp may also indicate that the interaction between the suppressor factor and any macrophage receptor is one characterized with a low binding affinity.
Experiments designed to evaluate which phagocytic receptors were inhibited by TsFmp showed that phagocytosis via Fc or mannan receptors was inhibited, whereas phagocytosis by complement receptors or by nonspecific mecha- (16) recently reported that T-suppressor factors from two independent suppressor cell networks shared common antigenic determinants with glycosylation-inhibitory protein and the phospholipase-inhibitory protein lipomodulin. This report is sure to lead to increased investigations into the possibility that the antigen-specific suppressor factors have the ability to inhibit enzymatic activities and that these properties contribute to their biologic activities in the generation of suppression.
Because TsFmp was known to be I-J restricted in its activity (2) and because we had previously shown that anti-I-J antisera would block the activity of TsFmp (2), we believed that the macrophage subset that responded to the factor could be similar in phenotype to the factor-presenting cells described by Dorf et al. (5, 8) ; those cells were I-A' and I-J-IM+. These subsets were removed from the peritoneal exudate population by a cold (4°C) panning procedure; both anti-I-J and anti-I-A treatment could remove the affected macrophage. The factor-presenting cell in the antinitrophenyl suppressor pathway studied by Dorf et (1, 10, 15, 19) . The nonspecific macrophage factor inhibited lymphocyte proliferative responses to mitogens, interleukin 2 production, and cutaneous hypersensitivity responses to haptens. Other characteristics shared by TsFmp and TsFeff include the requirement for antigenic stimulation before the suppressor factor was produced by the T-suppressor cell, I-J restriction, and ability to be absorbed by specific antigen. TsFeff is known to be I-J positive, and we have indirect evidence to suggest that TsFmp is I-J positive (2) .
This investigation has not defined the ultimate role of TsFmp in cryptococcosis. It seems unlikely that the suppressor molecule could significantly affect clearance of cryptococci, since only a small subset of macrophage is affected. On the other hand, it is known that this suppressor mechanism is common to other models of immune tolerance (4) , and thus the role of the suppressor mechanism seems best attributed to an effect on the establishment or maintenance of the tolerant state. The suppressor factor and the macrophage that responds to the factor have similarities to cells described in both the picryl and nitrophenyl pathways, and the possibility that TsFmp is the same as the factors described in those systems or shares functional activities with those factors must be examined.
In previous investigations (11) we were able to suppress phagocytosis of a subset of cells obtained from nonstimulated peritoneal cavities (resident peritoneal cells). Thus, the population of cells obtained by thioglycolate stimulation was not unique to the peritoneal exudate. We attempted to examine the effects of TsFmp on fully activated macrophages (unpublished observations); however, these cells were not phagocytic, and thus no effect was seen. The possibility that the action of TsFmp on the cell may be related to its stage of activation (resident, primed, or activated) is of interest and one that our preliminary studies may not have adequately addressed, since the populations of cells used could have contained cells in several stages of activation. It should be noted that whether unstimulated cells or thioglycolate-induced cells were used, the number of responsive macrophages in the population did not increase, indicating that the thioglycolate peritoneal stimulant, which would have cells present that are at different stages of macrophage differentiation than resident cells, did not increase the number of cells responsive to the suppressor factor.
We previously reported that when the total phagocytic capacity was used to examine the effect of the suppressor factor on the macrophage population, a more substantial effect on the phagocytic process was detected (4). In these experiments some cells were found that engulfed fewer particles but that were not totally inhibited in their phagocytic activity. Because conventional supernatants were used, it is possible that the effect was due to other factors present in the supernatant. In addition, the time of incubation of supernatants on the macrophage monolayer was long enough to allow secondary effects to occur in the culture such as induction of the macrophage population to release other phagocytosis-inhibiting substances (for example, prostaglandin E2). In the studies reported here, the phagocytic assay was modified as previously reported (2) to enhance the phagocytic activity of the macrophage populations. Under these conditions it was not possible to evaluate the total phagocytic capacity, since this determination required enumeration of the average number of yeast cells within each phagocytic macrophage. In our current assay most of the macrophages contain so many yeast cells that accurate counts of intracellular yeast cells are impossible.
The determination of the in vivo significance of the suppressor factor will come from experiments in which the fate of cryptococci is examined in animals after infusion of suppressor factor. Although preliminary experiments showed no effect on immediate clearance, we could not be sure that adequate amounts of suppressor factor were given. We must also examine the fate of yeast cells after infusion of suppressor factor over a longer term. If the suppressor factor is important in the establishment or maintenance of the tolerant state, its effect may require an in vivo induction period that could last several days. These issues will be the focus of our further investigations of this T suppressor factor.
